Sinopep-Allsino Biopharmaceutical Co.

Sinopep is a pioneering force in the pharmaceutical industry, dedicated to the advancement of peptides, oligonucleotides, and small molecules as crucial therapeutic solutions. With over 15 years of experience, Sinopep leverages cutting-edge technology and innovative practices to enhance human health and quality of life. The company specializes in Contract Development and Manufacturing Organization (CDMO) services, providing a comprehensive array of active pharmaceutical ingredients (APIs), intermediates, and drug formulations, including peptide and oligonucleotide NCEs (New Chemical Entities) and conjugates.

Sinopep is committed to excellence through its state-of-the-art facilities and a strong focus on research and development. With multiple R&D centers and a robust manufacturing presence, including sites in the USA and France, the company fosters collaboration and a socially responsible approach to drug development. Their mission reflects a steadfast dedication to saving lives, exemplified by their core values of integrity, technology-driven solutions, and customer focus. As a trusted global partner, Sinopep stands at the forefront of pharmaceutical innovation, continuously striving to offer cost-effective alternatives and breakthroughs to the healthcare market.